FI820020L - Immunoglobulinkonjugater - Google Patents

Immunoglobulinkonjugater

Info

Publication number
FI820020L
FI820020L FI820020A FI820020A FI820020L FI 820020 L FI820020 L FI 820020L FI 820020 A FI820020 A FI 820020A FI 820020 A FI820020 A FI 820020A FI 820020 L FI820020 L FI 820020L
Authority
FI
Finland
Prior art keywords
immunoglobulin
immunoglobulinkonjugater
fragment
conjugates
cancers
Prior art date
Application number
FI820020A
Other languages
English (en)
Finnish (fi)
Inventor
George Ferdinand Rowland
Robin George Simmonds
Original Assignee
Lilly Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Industries Ltd filed Critical Lilly Industries Ltd
Publication of FI820020L publication Critical patent/FI820020L/fi

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/395Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6801Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
    • A61K47/6803Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
    • A61K47/6805Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug being a vinca alkaloid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • External Artificial Organs (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FI820020A 1981-01-12 1982-01-05 Immunoglobulinkonjugater FI820020L (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8100847 1981-01-12

Publications (1)

Publication Number Publication Date
FI820020L true FI820020L (fi) 1982-07-13

Family

ID=10518931

Family Applications (1)

Application Number Title Priority Date Filing Date
FI820020A FI820020L (fi) 1981-01-12 1982-01-05 Immunoglobulinkonjugater

Country Status (27)

Country Link
EP (1) EP0056322B1 (ru)
JP (1) JPS57136529A (ru)
KR (1) KR860001149B1 (ru)
AT (1) ATE16603T1 (ru)
AU (1) AU549495B2 (ru)
BG (1) BG40318A3 (ru)
CA (1) CA1180660A (ru)
CS (1) CS235525B2 (ru)
DD (1) DD201447A5 (ru)
DE (1) DE3267474D1 (ru)
DK (1) DK5982A (ru)
EG (1) EG15599A (ru)
ES (1) ES508633A0 (ru)
FI (1) FI820020L (ru)
GB (1) GB2090837B (ru)
GR (1) GR75182B (ru)
HU (1) HU186025B (ru)
IE (1) IE52239B1 (ru)
IL (1) IL64722A (ru)
MX (1) MX7215E (ru)
NZ (1) NZ199421A (ru)
PH (1) PH18031A (ru)
PL (1) PL128529B1 (ru)
PT (1) PT74252B (ru)
RO (1) RO82758B (ru)
SU (1) SU1069628A3 (ru)
ZA (1) ZA82122B (ru)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4639456A (en) * 1980-06-10 1987-01-27 Omnichem S.A. Vinblastin-23-oyl amino acid derivatives
CA1203164A (en) * 1982-03-09 1986-04-15 Thomas J. Mckearn Antibody conjugates
ATE57187T1 (de) * 1983-03-30 1990-10-15 Lilly Industries Ltd Vincaleukoblastin-derivate.
GR79899B (ru) * 1983-03-30 1984-10-31 Lilly Industries Ltd
HUT34212A (en) * 1983-04-29 1985-02-28 Omnichem Sa Process for the production of new vindblastin conjugates
GB2148299B (en) * 1983-09-01 1988-01-06 Hybritech Inc Antibody compositions of therapeutic agents having an extended serum half-life
US4675400A (en) * 1985-06-17 1987-06-23 Eli Lilly And Company Bifunctional derivatives of 4-desacetyl indole-dihydroindole alkaloids
US4667030A (en) * 1985-06-17 1987-05-19 Eli Lilly And Company Hydrazide succinimide derivatives of antineoplastic indole-dihydroindole alkaloids
FI860456A (fi) * 1985-07-16 1987-01-17 Huhtamaeki Oy Laeaeketehdas Le Bis-indolalkaloiders proteinkonjugat, bis-indolalkaloider, deras framstaellning och anvaendning.
EP0232693A3 (fr) * 1985-12-16 1988-04-06 La Region Wallonne Conjugués de la vinblastine et de ses dérivés, procédé pour leur préparation et compositions pharmaceutiques les contenant
US4801688A (en) * 1986-05-27 1989-01-31 Eli Lilly And Company Hydrazone immunoglobulin conjugates
IL82579A0 (en) * 1986-05-27 1987-11-30 Lilly Co Eli Immunoglobulin conjugates
FR2626882B1 (fr) * 1988-02-08 1991-11-08 Ire Celltarg Sa Conjugues de derives de vinca comportant une chaine detergente en position c-3
US5094849A (en) * 1988-08-08 1992-03-10 Eli Lilly And Company Cytotoxic antibody conjugates of hydrazide derivatized vinca analogs via simple organic linkers
US5144012A (en) * 1988-08-08 1992-09-01 Eli Lilly And Company Cytotoxic drug conjugates
US5006652A (en) * 1988-08-08 1991-04-09 Eli Lilly And Company Intermediates for antibody-vinca drug conjugates
US5028697A (en) * 1988-08-08 1991-07-02 Eli Lilly And Company Cytotoxic antibody conjugates of hydrazide derivatized methotrexate analogs via simple organic linkers
US5043340A (en) * 1990-04-03 1991-08-27 Eli Lilly And Company Derivatives of 4-desacetyl VLB C-3 carboxhydrazide

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2456224A1 (de) * 1974-11-28 1976-08-12 Karl Dr Med Theurer Verwendung von nativen antikoerpern oder von antikoerper-fragmenten mit kovalent gebundenen oder konjugierten zytostatisch und/bzw. oder zytotoxisch wirkenden substanzen fuer die krebstherapie
GB1446536A (en) * 1975-02-21 1976-08-18 Yeda Res & Dev Pharmaceutically active compositions
FR2349335A1 (fr) * 1976-04-28 1977-11-25 Inst Int Pathologie Cellulaire Complexes d'alcaloides bis-indoliques du type vinblastine avec la tubuline, leur procede d'obtention et leur utilisation
JPS5470384A (en) * 1977-08-22 1979-06-06 Inst Obu Kiyansaa Risaachi Roi High molecular complex
FR2437213A1 (fr) * 1978-09-28 1980-04-25 Cm Ind Produits cytotoxiques formes par liaison covalente de la chaine a de la ricine avec un anticorps et leur procede de preparation
JPS55136235A (en) * 1979-04-09 1980-10-23 Teijin Ltd Antitumor protein complex and its preparation

Also Published As

Publication number Publication date
EP0056322B1 (en) 1985-11-21
GB2090837B (en) 1984-07-18
IL64722A (en) 1985-07-31
SU1069628A3 (ru) 1984-01-23
IE820023L (en) 1982-07-12
PT74252A (en) 1982-02-01
DK5982A (da) 1982-07-13
CS235525B2 (en) 1985-05-15
RO82758B (ro) 1984-01-30
ZA82122B (en) 1983-07-27
IE52239B1 (en) 1987-08-19
CA1180660A (en) 1985-01-08
ES8304149A1 (es) 1983-02-16
PL128529B1 (en) 1984-02-29
IL64722A0 (en) 1982-03-31
GR75182B (ru) 1984-07-13
PL234695A1 (ru) 1982-07-19
DE3267474D1 (en) 1986-01-02
MX7215E (es) 1988-01-08
RO82758A (ro) 1984-01-14
BG40318A3 (en) 1986-11-14
AU7927482A (en) 1982-07-22
ES508633A0 (es) 1983-02-16
NZ199421A (en) 1984-08-24
AU549495B2 (en) 1986-01-30
GB2090837A (en) 1982-07-21
PT74252B (en) 1983-08-24
ATE16603T1 (de) 1985-12-15
KR830008684A (ko) 1983-12-12
HU186025B (en) 1985-05-28
EG15599A (en) 1986-06-30
JPS57136529A (en) 1982-08-23
PH18031A (en) 1985-03-06
EP0056322A1 (en) 1982-07-21
DD201447A5 (de) 1983-07-20
KR860001149B1 (ko) 1986-08-18

Similar Documents

Publication Publication Date Title
ATE16603T1 (de) Immunoglobulinkonjugate.
NO166267C (no) Konjugat av et maalsoekende biologisk aktivt molekyl og en forbindelse inneholdende spormerkende metall, samt diagnostisk preparat inneholdende konjugatet.
GR1000712B (el) Νεα αντισωματα που αντιδρουν με τα ανθρωπινα καρκινωματα.
AU7366687A (en) Coupling agents for radiolabeling proteins
DE3885317D1 (de) Makromolekulare Platin-Antitumorverbindungen.
NO920040D0 (no) Syrelabile linkermolekyler
CY1110142T1 (el) Ουρικη οξειδαση ελευθερη συσσωματωματων για την παρασκευη μη ανοσογονων συζευγματων με πολυμερες
IL71366A (en) Immunoglobulin conjugates with vincaleukoblastine derivatives,their production and pharmaceutical compositions containing them
DE68923291D1 (de) Antikörper-konjugate mit zwei oder mehr kovalent vernetzten fc-regionen.
FR2432038A1 (fr) Conjugues marques d'hydrazide d'acide naphtalene-1,2-dicarboxylique chimioluminescent et leur procede de preparation
ATE87314T1 (de) Platin-arzneimittel.
SE8002602L (sv) Diagnostiskt forfarande

Legal Events

Date Code Title Description
FD Application lapsed

Owner name: LILLY INDUSTRIES LIMITED